These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12402066)

  • 21. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
    J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble interleukin-2 receptor levels in lupus nephritis.
    Laut J; Senitzer D; Petrucci R; Sablay LB; Barland P; Glicklich D
    Clin Nephrol; 1992 Oct; 38(4):179-84. PubMed ID: 1424303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
    Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
    Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum soluble interleukin-2 receptor in colorectal cancer.
    Murakami S; Satomi A; Ishida K; Murai H; Okamura Y
    Acta Oncol; 1994; 33(1):19-21. PubMed ID: 8142118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production.
    O'Hara RJ; Greenman J; MacDonald AW; Gaskell KM; Topping KP; Duthie GS; Kerin MJ; Lee PW; Monson JR
    Clin Cancer Res; 1998 Aug; 4(8):1943-8. PubMed ID: 9717823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of elevated serum soluble interleukin-2 receptor in gastric cancer.
    Wang YF; Wu XN; Zhou YH; Chen XF; Shen J; Wang HJ
    Chin Med J (Engl); 1994 Apr; 107(4):254-6. PubMed ID: 8088190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
    Nakase K; Tsuji K; Tamaki S; Tanigawa M; Ikeda T; Miyanishi E; Shiku H
    Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma.
    Kitai R; Sasaki H; Matsuda K; Tsunetoshi K; Yamauchi T; Neishi H; Matsumura K; Tsunoda A; Takeuchi H; Sato K; Kikuta K
    Brain Tumor Pathol; 2013 Jan; 30(1):34-9. PubMed ID: 22399193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis.
    Pforte A; Brunner A; Gais P; Burger G; Breyer G; Ströbel M; Häussinger K; Ziegler-Heitbrock HW
    Am Rev Respir Dis; 1993 Mar; 147(3):717-22. PubMed ID: 7680189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A progressive postoperative increase in the serum level of soluble receptors for interleukin-2 is an indicator of a poor prognosis in patients with gastric cancer.
    Maeta M; Saito H; Katano K; Kondo A; Tsujitani S; Makino M; Ikeguchi M; Kaibara N
    Int J Mol Med; 1998 Jan; 1(1):113-6. PubMed ID: 9852207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum soluble interleukin-2 receptor in patients with glomerulonephritis.
    Yorioka N; Hirabayashi A; Kanahara K; Takemasa A; Oda H; Joarder ZH; Yamakido M
    Am J Nephrol; 1990; 10(3):181-5. PubMed ID: 2382679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers.
    Motoi T; Uchiyama T; Uchino H; Ueda R; Araki K
    Jpn J Cancer Res; 1988 May; 79(5):593-9. PubMed ID: 2900231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.
    Tokano Y; Murashima A; Takasaki Y; Hashimoto H; Okumura K; Hirose S
    Ann Rheum Dis; 1989 Oct; 48(10):803-9. PubMed ID: 2818016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of increased serum soluble interleukin-2 receptor levels in patients on continuous ambulatory peritoneal dialysis.
    Takemasa A; Yorioka N; Oda H; Amimoto D; Ito T; Yamakido M
    Scand J Urol Nephrol; 2001 Apr; 35(2):141-6. PubMed ID: 11411658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.